Mineralys Therapeutics, Inc. business relationships
Companies named in Mineralys Therapeutics, Inc.’s 10-K filed 2026-03-12, and public companies whose annual reports name Mineralys Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 2 / 100 Top 5% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Mineralys Therapeutics, Inc.’s annual report 1
“However, the incremental reduction in systolic BP provided by successive lines of treatment does not always adequately enable patients to reach their BP goal.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.